Cargando…

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

BACKGROUND: Currently there are no effective treatments for many neurodegenerative diseases. Reliable biomarkers for identifying and stratifying these diseases will be important in the development of future novel therapies. Lewy Body Dementia (LBD) is considered an under diagnosed form of dementia f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heywood, Wendy E., Galimberti, Daniela, Bliss, Emily, Sirka, Ernestas, Paterson, Ross W., Magdalinou, Nadia K., Carecchio, Miryam, Reid, Emma, Heslegrave, Amanda, Fenoglio, Chiara, Scarpini, Elio, Schott, Jonathan M., Fox, Nick C., Hardy, John, Bahtia, Kailash, Heales, Simon, Sebire, Neil J., Zetterburg, Henrik, Mills, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666172/ https://www.ncbi.nlm.nih.gov/pubmed/26627638 http://dx.doi.org/10.1186/s13024-015-0059-y

Ejemplares similares

Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
por: Heywood, Wendy E., et al.
Publicado: (2016)

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)

A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
por: Paterson, R W, et al.
Publicado: (2016)

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
por: Buccellato, Francesca Romana, et al.
Publicado: (2021)

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
por: Fenoglio, Chiara, et al.
Publicado: (2013)

MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis
por: Fenoglio, Chiara, et al.
Publicado: (2012)

Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia(1)
por: Fenoglio, Chiara, et al.
Publicado: (2018)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016)

Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools
por: D’Anca, Marianna, et al.
Publicado: (2021)

Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration
por: D’Anca, Marianna, et al.
Publicado: (2022)

Genetics of Frontotemporal Lobar Degeneration
por: Galimberti, Daniela, et al.
Publicado: (2012)

Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
por: D’Anca, Marianna, et al.
Publicado: (2019)

IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
por: Saresella, Marina, et al.
Publicado: (2020)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration
por: Carlini, Valentina, et al.
Publicado: (2020)

Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]
por: Hansson, Karl, et al.
Publicado: (2022)

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
por: Wellington, Henrietta, et al.
Publicado: (2018)

Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations
por: Serpente, Maria, et al.
Publicado: (2015)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2023)

The Role of the Innate Immune System in Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia
por: Ridolfi, Elisa, et al.
Publicado: (2013)

Harmful Iron-Calcium Relationship in Pantothenate kinase Associated Neurodegeneration
por: Santambrogio, Paolo, et al.
Publicado: (2020)

Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: La Rosa, Francesca, et al.
Publicado: (2021)

An optimised method for the proteomic profiling of full thickness human skin
por: Bliss, Emily, et al.
Publicado: (2016)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Emerging Monogenic Complex Hyperkinetic Disorders
por: Carecchio, Miryam, et al.
Publicado: (2017)

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy
por: Arighi, Andrea, et al.
Publicado: (2015)

Lack of Association between the GPR3 Gene and the Risk for Alzheimer's Disease
por: Dominici, Roberto, et al.
Publicado: (2011)

Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy
por: Fonderico, Mattia, et al.
Publicado: (2017)

Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia
por: Fenoglio, Chiara, et al.
Publicado: (2022)

The clinical and genetic spectrum of primary familial brain calcification
por: Carecchio, Miryam, et al.
Publicado: (2023)

Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
por: Schneider, Susanne A, et al.
Publicado: (2013)

Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis
por: Ridolfi, Elisa, et al.
Publicado: (2013)

Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients
por: La Rosa, Francesca, et al.
Publicado: (2022)

Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation
por: Arighi, Andrea, et al.
Publicado: (2022)

A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease
por: Arcaro, Marina, et al.
Publicado: (2022)

Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV
por: Ellis, Ronald J., et al.
Publicado: (2020)

Sex differences in CSF biomarkers for neurodegeneration and blood‐brain barrier integrity
por: Skillbäck, Tobias, et al.
Publicado: (2021)

Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease
por: d'Orsi, Giuseppe, et al.
Publicado: (2023)

Parkinson disease in Gaucher disease
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2017)

Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer’s Disease
por: Visconte, Caterina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bfvbg59pj053e4ukhknku9gd51